Marcello Agosti is the Global Business Development Officer for Takeda Pharmaceutical Company Ltd. and is responsible for Takeda’s business development activities, including M&A and Corporate Development.
Mr. Agosti led the Shire acquisition and several other strategic acquisitions for Takeda, including ARIAD Pharmaceuticals and TiGenix. He also spearheaded a number of strategic divestments of non-core assets as part of Takeda’s commitment after the Shire acquisition. Marcello and his group continue to be active on inbound transactions in Takeda’s core therapy areas.
Prior to joining Takeda, Mr. Agosti worked in business development at Novartis in the U.K. and Switzerland. Before joining the pharmaceutical industry, he was a consultant at McKinsey & Company.
He holds an MBA from the University of Oxford and a Business Administration degree from Bocconi University, Milan.
Mr. Agosti is based in Boston.